Terms: = Prostate cancer AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha AND Prognosis
30 results:
1. Association between the apoptotic effect of Cabazitaxel and its pro-oxidant efficacy on the redox adaptation mechanisms in prostate cancer cells with different resistance phenotypes.
Eryilmaz IE; Egeli U; Cecener G
Cancer Biol Ther; 2024 Dec; 25(1):2329368. PubMed ID: 38485703
[TBL] [Abstract] [Full Text] [Related]
2. The APE1/REF-1 and the hallmarks of cancer.
Siqueira PB; de Sousa Rodrigues MM; de Amorim ÍSS; da Silva TG; da Silva Oliveira M; Rodrigues JA; de Souza da Fonseca A; Mencalha AL
Mol Biol Rep; 2024 Jan; 51(1):47. PubMed ID: 38165468
[TBL] [Abstract] [Full Text] [Related]
3. miRNAs and exosomal miRNAs in lung cancer: New emerging players in tumor progression and therapy response.
Hashemi M; Khosroshahi EM; Chegini MK; Abedi M; Matinahmadi A; Hosnarody YSD; Rezaei M; Saghari Y; Fattah E; Abdi S; Entezari M; Nabavi N; Rashidi M; Raesi R; Taheriazam A
Pathol Res Pract; 2023 Nov; 251():154906. PubMed ID: 37939448
[TBL] [Abstract] [Full Text] [Related]
4. The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy.
Ali A; Mekhaeil B; Biziotis OD; Tsakiridis EE; Ahmadi E; Wu J; Wang S; Singh K; Menjolian G; Farrell T; Mesci A; Liu S; Berg T; Bramson JL; Steinberg GR; Tsakiridis T
Commun Biol; 2023 Sep; 6(1):919. PubMed ID: 37684337
[TBL] [Abstract] [Full Text] [Related]
5. Alteration of the HIF-1α/VEGF Signaling Pathway and Disruption of the Cell Cycle by Second Generation Carbosilan Dendrimers.
Barrios O; Sánchez BG; Rodríguez-Prieto T; Cano J; Bort A; Gómez R; Díaz-Laviada I
Biomacromolecules; 2022 Dec; 23(12):5043-5055. PubMed ID: 36445323
[TBL] [Abstract] [Full Text] [Related]
6. Reduced HIF-1α Stability Induced by 6-Gingerol Inhibits Lung cancer Growth through the Induction of Cell Death.
Kim MJ; Ku JM; Choi YJ; Lee SY; Hong SH; Kim HI; Shin YC; Ko SG
Molecules; 2022 Mar; 27(7):. PubMed ID: 35408505
[TBL] [Abstract] [Full Text] [Related]
7. Hypoxia Drives Centrosome Amplification in cancer Cells via HIF1α-dependent Induction of Polo-Like Kinase 4.
Mittal K; Kaur J; Sharma S; Sharma N; Wei G; Choudhary I; Imhansi-Jacob P; Maganti N; Pawar S; Rida P; Toss MS; Aleskandarany M; Janssen EA; Søiland H; Gupta MV; Reid MD; Rakha EA; Aneja R
Mol Cancer Res; 2022 Apr; 20(4):596-606. PubMed ID: 34933912
[TBL] [Abstract] [Full Text] [Related]
8. An organoid-based drug screening identified a menin-MLL inhibitor for endometrial cancer through regulating the HIF pathway.
Chen J; Zhao L; Peng H; Dai S; Quan Y; Wang M; Wang J; Bi Z; Zheng Y; Zhou S; Liu Y; Chen C; Na F
Cancer Gene Ther; 2021 Feb; 28(1-2):112-125. PubMed ID: 32632269
[TBL] [Abstract] [Full Text] [Related]
9. Androgen Deprivation Induces Reprogramming of prostate cancer Cells to Stem-Like Cells.
Sánchez BG; Bort A; Vara-Ciruelos D; Díaz-Laviada I
Cells; 2020 Jun; 9(6):. PubMed ID: 32531951
[TBL] [Abstract] [Full Text] [Related]
10. Nuclear FGFR2 negatively regulates hypoxia-induced cell invasion in prostate cancer by interacting with HIF-1 and HIF-2.
Lee JE; Shin SH; Shin HW; Chun YS; Park JW
Sci Rep; 2019 Mar; 9(1):3480. PubMed ID: 30837551
[TBL] [Abstract] [Full Text] [Related]
11. Upregulation of the long non-coding RNA FALEC promotes proliferation and migration of prostate cancer cell lines and predicts prognosis of PCa patients.
Zhao R; Sun F; Bei X; Wang X; Zhu Y; Jiang C; Zhao F; Han B; Xia S
Prostate; 2017 Jul; 77(10):1107-1117. PubMed ID: 28585762
[TBL] [Abstract] [Full Text] [Related]
12. Transcriptome and Proteome Analyses of TNFAIP8 Knockdown cancer Cells Reveal New Insights into Molecular Determinants of Cell Survival and Tumor Progression.
Day TF; Mewani RR; Starr J; Li X; Chakravarty D; Ressom H; Zou X; Eidelman O; Pollard HB; Srivastava M; Kasid UN
Methods Mol Biol; 2017; 1513():83-100. PubMed ID: 27807832
[TBL] [Abstract] [Full Text] [Related]
13. Silibinin inhibits hypoxia-induced HIF-1α-mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: In vitro evidence and in vivo functional imaging and metabolomics.
Deep G; Kumar R; Nambiar DK; Jain AK; Ramteke AM; Serkova NJ; Agarwal C; Agarwal R
Mol Carcinog; 2017 Mar; 56(3):833-848. PubMed ID: 27533043
[TBL] [Abstract] [Full Text] [Related]
14. Bile acids destabilise HIF-1α and promote anti-tumour phenotypes in cancer cell models.
Phelan JP; Reen FJ; Dunphy N; O'Connor R; O'Gara F
BMC Cancer; 2016 Jul; 16():476. PubMed ID: 27416726
[TBL] [Abstract] [Full Text] [Related]
15. The anti-androgen drug dutasteride renders triple negative breast cancer cells more sensitive to chemotherapy via inhibition of HIF-1α-/VEGF-signaling.
von Wahlde MK; Hülsewig C; Ruckert C; Götte M; Kiesel L; Bernemann C
Gynecol Endocrinol; 2015 Feb; 31(2):160-4. PubMed ID: 25356777
[TBL] [Abstract] [Full Text] [Related]
16. Arginase II expressed in cancer-associated fibroblasts indicates tissue hypoxia and predicts poor outcome in patients with pancreatic cancer.
Ino Y; Yamazaki-Itoh R; Oguro S; Shimada K; Kosuge T; Zavada J; Kanai Y; Hiraoka N
PLoS One; 2013; 8(2):e55146. PubMed ID: 23424623
[TBL] [Abstract] [Full Text] [Related]
17. Peroxiredoxin 1 stimulates endothelial cell expression of VEGF via TLR4 dependent activation of HIF-1α.
Riddell JR; Maier P; Sass SN; Moser MT; Foster BA; Gollnick SO
PLoS One; 2012; 7(11):e50394. PubMed ID: 23185615
[TBL] [Abstract] [Full Text] [Related]
18. Exposure to hypoxia following irradiation increases radioresistance in prostate cancer cells.
Hennessey D; Martin LM; Atzberger A; Lynch TH; Hollywood D; Marignol L
Urol Oncol; 2013 Oct; 31(7):1106-16. PubMed ID: 22130126
[TBL] [Abstract] [Full Text] [Related]
19. Comparative analysis of biological profiles of benign prostate hyperplasia and prostate cancer as potential diagnostic, prognostic and predictive indicators.
Makarewicz R; Zyromska A; Andrusewicz H
Folia Histochem Cytobiol; 2011; 49(3):452-7. PubMed ID: 22038225
[TBL] [Abstract] [Full Text] [Related]
20. Combined treatment targeting HIF-1α and Stat3 is a potent strategy for prostate cancer therapy.
Reddy KR; Guan Y; Qin G; Zhou Z; Jing N
Prostate; 2011 Dec; 71(16):1796-809. PubMed ID: 21480310
[TBL] [Abstract] [Full Text] [Related]
[Next]
